These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2893513)

  • 41. Brain atrophy and intellectual impairment in tardive dyskinesia.
    Ueyama K; Fukuzako H; Takeuchi K; Hirakawa K; Fukuzako T; Hokazono Y; Takigawa M; Matsumoto K
    Jpn J Psychiatry Neurol; 1993 Mar; 47(1):99-104. PubMed ID: 8105130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tardive dyskinesia and steady-state serum levels of thiothixene.
    Yesavage JA; Tanke ED; Sheikh JI
    Arch Gen Psychiatry; 1987 Oct; 44(10):913-5. PubMed ID: 2889439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tardive dyskinesia in outpatients on depot phenothiazine.
    Neehall J
    West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tardive dyskinesia and new antipsychotics.
    Correll CU; Schenk EM
    Curr Opin Psychiatry; 2008 Mar; 21(2):151-6. PubMed ID: 18332662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?
    Schulze TG; Müller DJ; Krauss H; Marwinski K; Maroldt AO; Novo Y Fernández A; Fimmers R; Held T; Maier W; Nöthen MM; Rietschel M
    Eur Psychiatry; 2001 Feb; 16(1):71-4. PubMed ID: 11246296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia.
    Yoder KK; Hutchins GD; Morris ED; Brashear A; Wang C; Shekhar A
    Schizophr Res; 2004 Dec; 71(2-3):371-5. PubMed ID: 15474908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to 'tardive' dyskinesia independent of extent of neuroleptic medication.
    Waddington JL; Youssef HA
    Ir Med J; 1985 May; 78(5):143-6. PubMed ID: 2861172
    [No Abstract]   [Full Text] [Related]  

  • 49. Factors in the development of severe forms of tardive dyskinesia.
    Yassa R; Nair NP; Iskander H; Schwartz G
    Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Tardive dyskinesia: a current review].
    Shriqui CL
    Can J Psychiatry; 1988 Oct; 33(7):637-44. PubMed ID: 2904299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive impairment in tardive dyskinesia.
    Wegner JT; Kane JM; Weinhold P; Woerner M; Kinon B; Lieberman J
    Psychiatry Res; 1985 Dec; 16(4):331-7. PubMed ID: 2868476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment.
    Byne W; White L; Parella M; Adams R; Harvey PD; Davis KL
    Int J Geriatr Psychiatry; 1998 Jul; 13(7):473-9. PubMed ID: 9695037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tardive dyskinesia and depressive symptoms in schizophrenics.
    Richardson MA; Pass R; Bregman Z; Craig TJ
    Psychopharmacol Bull; 1985; 21(1):130-5. PubMed ID: 2858905
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of neuroleptics and tardive dyskinesia on smooth-pursuit eye movement in chronic schizophrenics.
    Spohn HE; Coyne L; Spray J
    Arch Gen Psychiatry; 1988 Sep; 45(9):833-40. PubMed ID: 2901252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing epidemiology of tardive dyskinesia: an overview.
    Jeste DV; Wyatt RJ
    Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia.
    Zhang XY; Chen DC; Qi LY; Wang F; Xiu MH; Chen S; Wu GY; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2009 Sep; 205(4):647-54. PubMed ID: 19529921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
    Szafrański T
    Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.